Quality Tested Third-Party Verified Highly Purified U.S. Based Expert Support
PhysIQ PeptidesPhysIQ Peptides
Back to Shop
Semaglutide 20mg research peptide vial

Semaglutide

Semaglutide

Semaglutide is a 31-amino-acid analog of human glucagon-like peptide-1 (GLP-1) with about 94% sequence homology to the native hormone. Two structural changes distinguish it: an α-aminoisobutyric acid (Aib) at position 8, which protects against cleavage by the enzyme DPP-4, and a lysine side chain at position 26 acylated with a C18 fatty diacid through a γGlu-OEG-OEG linker, which promotes reversible albumin binding. Together these extend its half-life to roughly a week in pharmacokinetic studies, compared with minutes for native GLP-1.

The design and structure–activity work behind semaglutide was published by Lau and colleagues in the Journal of Medicinal Chemistry in 2015, and it has since become a benchmark molecule for studying GLP-1 receptor pharmacology and fatty-acid acylation as a half-life strategy.

Semaglutide is the active ingredient in FDA-approved prescription drugs; this product is a research-grade material, not a drug product. PhysIQ Peptides supplies it as a lyophilized powder, third-party tested for purity and identity, for in vitro and laboratory research use only.

Select size

Choose how to buy

Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.

$140.00per vial · 20mg
Ask a Question
Third-party tested · Purity 99% · For laboratory research use only.
Purity
99%
Form
Powder (lyophilized)
CAS Number
910463-68-2
Molecular Formula
C187H291N45O59
Molecular Weight
4113.58 g/mol
Available sizes
20mg, 30mg

Sequence

H-Aib-EGTFTSDVSSYLEGQAAK(γGlu-2xOEG-C18 diacid)EFIAWLVRGRG-OH

Mechanism of Action

Semaglutide is a selective agonist of the GLP-1 receptor, a class B G protein-coupled receptor. Receptor activation stimulates adenylyl cyclase and raises intracellular cAMP, which in pancreatic beta-cell models potentiates glucose-dependent insulin secretion. Its albumin binding and DPP-4 resistance give it a prolonged exposure profile, which is why it is frequently used in studies comparing short- and long-acting incretin analogs.

Research Areas

  • ●GLP-1 receptor pharmacology
  • ●Incretin signaling and beta-cell models
  • ●Peptide acylation and albumin binding
  • ●DPP-4 resistance and half-life engineering

Selected References

  • Lau J, et al. J Med Chem. 2015;58(18):7370-7380.

Related Products

Semax research peptide vial

Semax

Purity
99%
Size
10mg
Form
Powder
$35.00Per Unit
Sermorelin research peptide vial

Sermorelin

Purity
99%
Size
5mg
Form
Powder
$35.00Per Unit
SLU-PP-332 research peptide vial

SLU-PP-332

Purity
≥99%
Size
10mg
Form
Powder
$119.00Per Unit
SNAP-8 research peptide vial

SNAP-8

Purity
≥99%
Size
10mg
Form
Powder
$43.00Per Unit